Question

Difficulty: Very hardPreventive Care and Immunizations

A mother brings her male infant to the office for a health supervision visit. The child is chronologically 15 months old. He was delivered at 28 weeks gestation due to severe maternal preeclampsia. He spent 8 weeks in the neonatal intensive care unit but was discharged without major complications. His immunizations were current up until his 6-month visit. Due to a temporary out-of-state relocation, he missed his subsequent well-child checks. At 11 months of chronological age, he was hospitalized for 6 days with prolonged high fever, bilateral nonexudative conjunctivitis, oral mucosal changes, and cervical lymphadenopathy. He received treatment with high-dose intravenous immunoglobulin (IVIG) and high-dose aspirin, which led to rapid clinical improvement. He currently takes no medications.

During today's visit, the mother expresses deep concern because the child is not yet walking without support, whereas his older sister walked at 11 months. The patient is able to pull himself to a standing position and walk along the couch. He accurately picks up small cereal pieces using his thumb and index finger. He points to his toys when he wants them and calls his parents 'mama' and 'dada' appropriately. Vital signs and physical examination are unremarkable.

Which of the following is the most appropriate management for this patient today?

  1. Reassure the mother regarding his development and administer the DTaP, Hib, PCV, and hepatitis A vaccinesAnswer
  2. B
    Reassure the mother regarding his development and administer the DTaP, Hib, PCV, hepatitis A, MMR, and varicella vaccines
  3. C
    Refer the child for early intervention and administer the DTaP, Hib, PCV, and hepatitis A vaccines
  4. D
    Refer the child for early intervention and administer the DTaP, Hib, PCV, hepatitis A, MMR, and varicella vaccines
  5. E
    Reassure the mother regarding his development and defer all vaccines until 11 months after his intravenous immunoglobulin therapy

Answer

Reassure the mother regarding his development and administer the DTaP, Hib, PCV, and hepatitis A vaccines
The correct management combines reassuring the mother because the infant's development is appropriate for his corrected age, and administering only inactivated vaccines because live vaccines are temporarily contraindicated following high-dose intravenous immunoglobulin (IVIG) therapy. For infants born prematurely, chronological age should be corrected for the degree of prematurity when assessing developmental milestones until 24 months of age. This child was born at 28 weeks gestation (12 weeks or 3 months premature). At a chronological age of 15 months, his corrected age is 12 months. His milestones—cruising, fine pincer grasp, specific 'mama/dada', and pointing—are perfectly aligned with a 12-month developmental level. Therefore, reassurance rather than early intervention is appropriate. Furthermore, he is due for several vaccines since he missed his visits after 6 months. High-dose IVIG, standard therapy for Kawasaki disease (which he had at 11 months), contains antibodies that interfere with the replication of live-attenuated viral vaccines. Consequently, measles, mumps, and rubella (MMR) and varicella vaccines must be deferred for 11 months after high-dose IVIG administration. Inactivated vaccines (DTaP, Hib, PCV, hepatitis A) are not affected by circulating passive antibodies and should be administered today.

Step-by-Step Solution

1
Calculate the patient's corrected age to accurately assess developmental milestones.
The infant is 15 months chronological age, but was born at 28 weeks gestation (12 weeks, or 3 months, premature). Therefore, his corrected age is 12 months.
Premature infants must have their chronological age adjusted for the degree of prematurity until they reach 24 months of age to avoid false diagnoses of developmental delay.
2
Compare the patient's current abilities to expected milestones for a 12-month-old.
Cruising (walking along furniture), neat pincer grasp, specific 'mama/dada', and pointing are all normal and expected milestones for a 12-month-old. No developmental delay is present.
Proper assessment determines whether parental reassurance or an early intervention referral is medically indicated.
3
Identify the implications of the patient's recent treatment for Kawasaki disease on his immunization schedule.
The patient received high-dose IVIG at 11 months of age. Live-attenuated vaccines must be deferred for 11 months post-infusion.
Passive antibodies present in IVIG will neutralize live vaccine viruses (e.g., MMR, varicella) before they can elicit an immune response, rendering them ineffective.
4
Determine which of the indicated catch-up vaccines are live versus inactivated.
MMR and varicella are live vaccines and must be deferred. DTaP, Hib, PCV, and hepatitis A are inactivated vaccines and can be administered safely today.
Inactivated vaccines are not affected by circulating passive antibodies from IVIG and are necessary to bring the patient up to date on his immunization schedule.

Key Concept

Assessment of developmental milestones using corrected age for prematurity, and the contraindication of live-attenuated vaccines following high-dose intravenous immunoglobulin (IVIG) therapy.
Estimated Time:1m 30s
Rate this question